In addition, many adults (67%) also think policymakers should keep access- and coverage-related factors in mind, namely ...
Various agreements with the Trump administration could have long-term ramifications for Medicaid access and global pricing strategy.
As the FDA ends its phased exemption period for most trading partners, Two Labs’ Michael Rowe warns that DSCSA compliance is ...
Cheryl Allen, BS Pharm, MBA, founding partner, Curatio Scientia Advisors, discusses how the convergence of patient access ...
In today’s Pharma Pulse, Augmentin XR is the first drug approved under the FDA's new CNPV pilot program and much more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback